EDAP
EDAP TMS SA
NASDAQ: EDAP · HEALTHCARE · MEDICAL DISTRIBUTION
$4.16
+0.23% today
Updated 2026-05-26
Market cap
$156.30M
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-0.82
Dividend yield
—
52W range
$1 – $5
Volume
0.0M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.0
Profitability
F5.7
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$5.83
+40.14%
12-Month target
—
—
Intrinsic (DCF)
$8.41
Margin of safety
+41.74%
0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 13.90% QoQ
+ 41.74% below intrinsic value
Risks
- Thin margins at -41.70%
- Negative free cash flow $-3.73M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $55.11M | $60.42M | $64.11M | $70.75M | $74.07M |
| Net income | $-2.93M | $-21.18M | $-19.02M | $-29.34M | $-9.12M |
| EPS | — | — | — | — | $-0.82 |
| Free cash flow | $-5.21M | $-18.97M | $-17.68M | $-22.17M | $-3.73M |
| Profit margin | -5.32% | -35.05% | -29.66% | -41.47% | -41.70% |
Peer comparison
Smart narrative
EDAP TMS SA trades at $4.16. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $74.07M. with profit margins at -41.70%. Our DCF model estimates intrinsic value at $8.41.
Frequently asked questions
What is EDAP TMS SA's stock price?
EDAP TMS SA (EDAP) trades at $4.16, on a P/S of 2.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is EDAP TMS SA overvalued?
EDAP TMS SA carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $8.41 versus the $4.16 price, a 41.7% margin of safety on a cash flow basis.
What is the price target of EDAP TMS SA (EDAP)?
The 12-month analyst consensus target is $5.83, about 40.1% above the current $4.16. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of EDAP TMS SA (EDAP)?
Our DCF model estimates intrinsic value at $8.41, a +41.7% margin of safety versus today's $4.16. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is EDAP TMS SA's revenue?
EDAP TMS SA's trailing twelve-month revenue is $74.07M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.11x
ROE-124.00%
Beta-0.10
50D MA$3.68
200D MA$3.02
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—